Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
10 Different Stocks To Buy A 10-Year-Old 2nd Child
04:35am, Thursday, 27'th May 2021
This is a follow-up to my January 2018 article "10 First Stocks To Buy A 10-Year Old", reflecting on how choosing stocks for my 2nd 10-year old is different. 2nd children often look up to older siblin
Fresenius: Q1 2021 Confirms The Positive Outlook
10:27pm, Wednesday, 12'th May 2021
Fresenius has reported 1Q21 - and the results confirm my positive outlook on the company. Since my initial article and investment, the position in my portfolio, invested in the DAX ticker, has appreci
Fresenius Medical (FMS) Gains 1.1% Since Q1 Earnings Beat
10:31am, Wednesday, 12'th May 2021
Fresenius Medical's (FMS) first-quarter earnings benefit from organic growth in Health Care Products segment, and performance in Asia Pacific.
Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q1 2021 Results - Earnings Call Transcript
02:13am, Sunday, 09'th May 2021
Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q1 2021 Results - Earnings Call Transcript
Fresenius Medical Care Appears To Be Fairly Valued
09:00am, Monday, 15'th Mar 2021
Fresenius Medical Care is the world's leading dialysis company poised to profit from strong underlying tailwinds.
Fresenius: An 8-20% Undervalued German Giant
03:58am, Tuesday, 09'th Mar 2021
Fresenius is a massive $35B market cap company out of Germany in the healthcare sector. It's one of few German companies with an alternative listed on the NYSE. This makes investing in the company or
Fresenius Medical (FMS) Q4 Earnings Beat, Revenues Miss
06:50am, Wednesday, 24'th Feb 2021
Fresenius Medical's (FMS) fourth-quarter earnings benefit from strength in Health Care Products segment, and performance across EMEA and Asia Pacific.
Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q4 2020 Results - Earnings Call Transcript
02:58pm, Tuesday, 23'rd Feb 2021
Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q4 2020 Results - Earnings Call Transcript
Recap: Fresenius Medical Care Q4 Earnings
09:28am, Tuesday, 23'rd Feb 2021
Shares of Fresenius Medical Care (NYSE:FMS) rose 0.0% after the company reported Q4 results. Quarterly Results Earnings per share fell 50.00% year over year to $0.76, which missed the estimate of $0.7
Is Fresenius (FMS) Stock Undervalued Right Now?
12:48pm, Thursday, 21'st Jan 2021
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
4 MedTech Underperformers Poised for a Turnaround in 2021
10:32am, Thursday, 21'st Jan 2021
Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.
WALTHAM, Mass., Jan. 11, 2021 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for people with chronic kidney failure, announced today that the company's F
Fresenius SE: Still Undervalued
06:26am, Sunday, 10'th Jan 2021
Fresenius SE: Still Undervalued
Fresenius Medical Care Is A Global Market Leader And A Bargain
07:25am, Tuesday, 05'th Jan 2021
Fresenius Medical Care might not be a ten-bagger in the next few years. Conversely, the stock currently offers a very good risk/reward ratio.
Is Fresenius (FMS) a Solid Growth Stock? 3 Reasons to Think " Yes "
01:33pm, Wednesday, 30'th Dec 2020
Fresenius (FMS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
